Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 39934772

The association between rs2228226 and postoperative clinical outcomes in gastric adenocarcinoma: a retrospective study.

Haowen Wu·Xinxiong Li·Yuan Dang·Yawei Zhang·Zaizhong Zhang·Bowen Zhang·Qinglong Cai·Lie Wang·Meiping Wang·Chunhong Xiao
View original source ↗Export metadata ↓

Abstract

BACKGROUND: This study aims to investigate the differences in postoperative prognosis associated with the single nucleotide polymorphism (SNP) rs2228226 (G&#x2009;>&#x2009;C) in gastric adenocarcinoma (GAC) patients. METHODS: This study enrolled 661 patients with locally advanced (pT4a) GAC after surgery. DNA was extracted from their tissues and genotyped for rs2228226 using a MassARRAY Analyzer. Based on the patients' clinical and pathological information, a multifactorial Cox regression analysis was performed to assess the correlation between rs2228226 and the clinical prognosis of pT4a GAC patients. Survival differences among patients who received postoperative chemotherapy were also examined according to rs2228226. RESULTS: After excluding patients with distant metastasis, loss to follow-up, and those not meeting the inclusion criteria, a total of 463 patients with complete data were included. The rs2228226 genotype distribution was as follows: C/C&#x2009;=&#x2009;57 (12.3%), G/C&#x2009;=&#x2009;200 (43.2%), and G/G&#x2009;=&#x2009;206 (44.5%). Patients with the C/C genotype had significantly shorter disease-free survival (DFS&#x2009;=&#x2009;12&#xa0;months) and overall survival (OS&#x2009;=&#x2009;27&#xa0;months) compared to those with the G/C or G/G genotype (DFS&#x2009;=&#x2009;19&#xa0;months, log-rank P&#x2009;=&#x2009;0.003; OS&#x2009;=&#x2009;35&#xa0;months, log-rank P&#x2009;=&#x2009;0.002). Further analysis of patients receiving chemotherapy identified the C/C genotype, advanced age, lymph node metastasis, degree of differentiation, and failure to achieve R0 resection as independent risk factors for tumor recurrence and metastasis (P&#x2009;<&#x2009;0.05). The C/C genotype, lymph node metastasis, and tumor recurrence and metastasis were independent risk factors for mortality (P&#x2009;<&#x2009;0.05). CONCLUSIONS: In pT4a GAC patients undergoing postoperative chemotherapy, the C/C genotype at rs2228226 is an independent risk factor for tumor recurrence, metastasis, and death. The rs2228226 (G&#x2009;>&#x2009;C) polymorphism may serve as a potential biomarker for predicting prognosis after chemotherapy in GAC.

Explore related subjects

HumansStomach NeoplasmsMaleFemalePolymorphism, Single NucleotideMiddle AgedAdenocarcinomaRetrospective StudiesAgedPrognosisTreatment OutcomeAdultPostoperative PeriodGenotypeBiomarkersGastric adenocarcinomars2228226Journal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Haowen Wu, Xinxiong Li, Yuan Dang, Yawei Zhang, Zaizhong Zhang, Bowen Zhang, Qinglong Cai, Lie Wang, Meiping Wang, Chunhong Xiao. 2025-02-11. The association between rs2228226 and postoperative clinical outcomes in gastric adenocarcinoma: a retrospective study.. https://doi.org/10.1186/s12920-025-02102-x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗
PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗
PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗